Evaluation of annotations for cancer gene panel testing using a genome-guided system

ANNALS OF ONCOLOGY(2022)

Cited 0|Views5
No score
Abstract
In Japan, oncogene panel testing is covered by public insurance since June 2019, and it is now mandatory to explain to the patients the results of testing, after interpretation by an Expert Panel (EP) at cancer genomic medicine hospitals. Therefore, the work burden of interpreting genomic data and proposing treatment based on the results is very heavy on clinicians, making an automated annotation system desirable.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined